Cibc World Market Inc. Tg Therapeutics, Inc. Transaction History

Cibc World Market Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$15.2 - $35.51 $98,800 - $230,815	-6,500 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$25.27 - $54.9 $164,255 - $356,850	6,500 New	6,500 $338,000
Q3 2018 Nov 09, 2018	SELL	$5.15 - $14.0 $138,020 - $375,200	-26,800 Closed	0 $0
Q2 2018 Aug 08, 2018	SELL	$12.5 - $15.0 $83,125 - $99,750	-6,650 Reduced 19.88%	26,800 $352,000
Q1 2018 May 18, 2018	BUY	$8.7 - $16.8 $26,099 - $50,400	3,000 Added 9.85%	33,450 $475,000
Q4 2017 Feb 01, 2018	BUY	$7.35 - $12.3 $223,807 - $374,535	30,450	30,450 $250,000

338

88.3M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.29B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

Stay updated on Cibc World Market Inc. with notifications on news.